Exousia Bio, Inc. — Net Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2903e526-72f7-4891-bd7f-dfc3817c17c8/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $51.4k | 2024-06-01 – 2025-05-31 | evidence 0001683168-25-007621 |
| FY 2023 | $-25.8k | 2023-06-01 – 2024-05-31 | evidence 0001683168-24-006126 |
| FY 2022 | $-56.4k | 2022-06-01 – 2023-05-31 | evidence 0001683168-23-006240 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).